Verified analytical profiles with multi-ton generic peptide APIs and metabolic analogs available for global procurement.
Bridging cellular redox biochemistry with advanced solid-phase peptide synthesis (SPPS) and targeted delivery technology.
End-to-end biopharmaceutical research & synthesis base.
Pharma-grade route design and process engineering.
Global leader in scalable peptide API output.
Strict impurity profiling & low endotoxin standards.
Nicotinamide Adenine Dinucleotide (NAD+) is the central coenzyme for cellular respiration, PARP-driven DNA repair, and sirtuin longevity activation. However, native NAD+ suffers from poor oral bioavailability, enzymatic degradation by CD38, and low transmembrane permeability.
The convergence of peptide engineering with NAD+ precursors represents a major technological breakthrough. Global procurement trends show biopharma brands increasingly demanding cell-penetrating peptides (CPPs) and mitochondrial-targeting peptide vectors to ferry cofactors across intracellular barriers.
Operating from the high-tech biopharma cluster of Heda Medicine Valley in Hangzhou, China, our manufacturing infrastructure consolidates automated liquid handling, industrial multi-ton solid-phase peptide synthesis (SPPS), and preparative continuous chromatography.
By leveraging an optimized domestic chemical supply chain for protective amino acids (Fmoc/tBu), coupling reagents (HATU, PyBOP), and specialized cleavage matrices, we offer international buyers a 35% to 50% operational cost advantage without compromising cGMP or ISO compliance.
Our dedicated R&D center specializes in complex molecular architecture: cyclic peptides, stapled peptides, PEGylation, lipidation, and specialized ligand attachments targeting sirtuin modulators.
Every batch of custom NAD+ peptide analogue undergoes comprehensive identity testing including high-resolution mass spectrometry (HRMS), chiral amino acid analysis, and residual trifluoroacetic acid (TFA) to acetate counter-ion conversion to ensure therapeutic biocompatibility.
Engineered peptides engineered for metabolic optimization, aesthetic longevity, and clinical formulation stability.
Targeted co-factor delivery to counteract neurodegenerative degeneration, microvascular decline, and age-related mitochondrial loss.
Transdermal delivery vectors combined with signal peptides and GHK-Cu complexes to stimulate extracellular matrix synthesis.
Synergistic formulations combining GLP-1/GIP receptor agonists (Semaglutide, Tirzepatide) with NAD+ metabolic stimulants.
Full support for registration dossier drafting (CMC, DMF, stability assays) for custom investigational peptide drug candidates.
Enterprise procurement specifications require deep analytical rigor. Verify every supplier across these critical analytical checkpoints.
Review raw gradient HPLC traces, not solely aggregated numbers. Confirm that critical pair separation differentiates insertion, deletion, and racemized D-amino acid impurities.
Electrospray Ionization (ESI-MS) or MALDI-TOF must align directly with theoretical molecular mass calculations. Request MS/MS peptide fragmentation mapping for sequence proof.
Synthetic peptides hold water and counter-ions. Differentiate between total bulk powder weight and absolute net peptide fraction calculated via quantitative amino acid analysis.
Standard synthesis yields trifluoroacetate (TFA) salts, which display cellular cytotoxicity. Thinheal offers advanced ion exchange chromatography to provide non-toxic acetate or hydrochloride salts.
Residual volatile solvents (acetonitrile, DMF, DCM, ether) must conform to ICH Q3C limits via Headspace GC. Heavy metals must remain below 10-20 ppm using ICP-MS validation.
Ensure that processes developed in 1-liter laboratory reactors scale smoothly into 500-liter automated synthesizers without unexpected aggregation, yield collapse, or solubility drop.
Cold-chain peptide distribution engineered for stability. We operate dedicated geographic desks providing localized regulatory oversight, import licensing guidance, and express dry-ice shipping.
Headquarters & Synthesis Facility:
Phase 5, Heda Medicine Valley, Chengrui Street Intersection, Xingfu North Road, Qiantang District, Hangzhou, Zhejiang, China.
Central Office: +86 0571-86758863 | [email protected]
Everything procurement officers and lead chemists need to know regarding contract terms, custom projects, and compliance.
An NAD+ peptide refers to a synthetic peptide sequence designed either as a functional conjugate with NAD+ precursors (such as NMN or NR) or as a cell-penetrating carrier peptide (CPP) engineered to facilitate transmembrane mitochondrial entry. Unlike unassisted oral nicotinamide riboside, which is rapidly hydrolyzed systemically, peptide-linked analogs target specific cellular receptors, elevating intracellular NAD+/NADH ratios while minimizing enzymatic degradation by serum nucleosidases and CD38.
Thinheal operates an integrated R&D facility and industrial production park in Hangzhou equipped with high-capacity solid-phase reactors (up to 1,000L reaction volume) and continuous axial-compression preparative HPLC columns. Our nearly 20 years of hands-on management experience enable optimized coupling cycles, reduced raw-solvent consumption, and minimal step-loss across multi-step assembly of complex therapeutic sequences.
Every commercial delivery is supplied with a comprehensive Certificate of Analysis (CoA) containing analytical reverse-phase HPLC chromatograms confirming purity (typically ≥98% to ≥99%), Mass Spectrometry (MS) identity profiles, quantitative amino acid analysis (AAA), residual water content via Karl Fischer titration, residual organic solvent testing by Headspace GC, bacterial endotoxin testing via LAL, and specific counter-ion determination.
Yes. Synthetic peptides produced via Fmoc chemistry normally retain residual TFA ions, which are cytotoxic to cultured cells and unsuitable for pharmaceutical and cosmetic final products. Thinheal provides specialized ion-exchange chromatography columns to exchange counter-ions into acetate (AcOH) or hydrochloride (HCl) salts, ensuring residual TFA levels remain well below 0.1% or non-detectable thresholds.
Lyophilized peptides are shipped under controlled thermal conditions. Standard research orders utilize temperature-regulated vacuum insulation packs with dry gel ice packs, while high-value commercial batches, pre-dissolved solutions, and moisture-sensitive therapeutic APIs are packed with active dry-ice logging monitors. We coordinate directly with global logistics partners (FedEx, DHL, specialized air freight) to handle clearance and doorstep arrival worldwide.
Explore our validated synthetic molecules for immune, metabolic, and aesthetic applications.
Thin
